Drug intelligence / Profile preview

Europenem

Development stage
Unknown
Lead developer
AAR Pharma
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Europenem is a carbapenem antibiotic distributed by AAR Pharma in Ukraine, containing ertapenem as its active pharmaceutical ingredient. As a small molecule beta-lactam, it functions by binding to penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. This binding inhibits the final transpeptidation step of peptidoglycan synthesis, preventing the cross-linking of peptidoglycan chains and effectively halting bacterial cell wall synthesis, which leads to cell lysis and death. Europenem is effective against a broad spectrum of Gram-positive and Gram-negative aerobic and anaerobic bacteria and is indicated for the treatment of moderate to severe bacterial infections, including intra-abdominal infections, community-acquired pneumonia, and complicated urinary tract infections.

Brand names
EuropenemЄВРОПЕНЕМ
Other names
ЄВРОПЕНЕМ-AAR Pharma
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on Europenem.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Europenem.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call